In the Spotlight

Cancer in Special Situations/ Populations

Vaccinate cancer patients against COVID-19: experts address major uncertainties

At an ESMO Live Roundtable, a panel of experts discussed the benefits and risk of COVID-19 vaccination in patients with cancer, the practicalities of vaccinating those undergoing immunosuppressant treatment and the potential advantages and disadvantages of flexible dosing intervals.

26 Jan 2021

Therapy

Switching from intravenous to oral or subcutaneous cancer treatment: a sustainable approach?

Despite alternative modes of administering anticancer medicines have reinforced the idea that at-home cancer care may be sometimes feasible as well as preferred by patients, there are concerns about costs of and accessibility to these new opportunities.

11 Dec 2020

Cancer Prevention

Cancer screening programmes, a long road back to normal

In many countries, cancer screening activities are still suffering a complete shutdown, and according to public policy experts this may limit opportunities of a timely diagnosis especially to socio-economically vulnerable populations.

30 Oct 2020

Cancer in Special Situations/ Populations

Is COVID-19 turning back the clock for patient empowerment?

After years of progress in empowering patients with cancer to play a more active role in their care, the COVID-19 pandemic is leaving many feeling anxious with little control over if, when or how they will receive a diagnosis or treatment.

20 Oct 2020

Cancer Research

Increased bureaucracy downgrades efficiency in cancer research

Nearly 20 years since the first steps to harmonise clinical trial regulations across Europe, bureaucracy is now stifling research in oncology. A newly established ESMO Clinical Research Observatory (ECRO) Task Force identifies priorities for action.

20 Oct 2020

Cancer Research

Does academic research really need so much administrative work?

20 Oct 2020

Cancer in Special Situations/ Populations

It is time to extend the continuity of cancer care beyond hospital walls

General practitioners handle a lifetime of health concerns for their patients – so why exclude them from cancer management?

20 Oct 2020

Cancer Research

What would have been unthinkable before became feasible in the interest of patient safety

Temporary accommodations made to weather the COVID-19 pandemic could accelerate lasting reform of clinical trial methodology.

20 Oct 2020

Cancer in Special Situations/ Populations

Young oncologists in the coronavirus crisis: a learning opportunity

Despite some share the concern of having their career plans delayed or disrupted by the pandemic, the new challenges emerged in these unprecedented times represent a unique opportunity to grow-up as oncology professionals and get ready to a new scenario where team working, humanisation of care and virtual education will be more crucial than ever.

20 Oct 2020

Cancer Control Principles

Telemedicine: the good and bad of living a hype

New forms of remote cancer care services have been piloted since the COVID-19 outbreak to offer support to patients while complying with hospital visiting restrictions. Despite a renewed popularity of telemedicine, digital services implemented so quickly may increase the risk of unmet expectations in the future.

20 Oct 2020

1
2
3
4
5
6
7
8
9
10 of 11
11